Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00474630
Status:
COMPLETED
Last Update Posted:
2014-11-21
First Post:
2007-05-15
Brief Title:
A Safety and Efficacy Study Comparing Naltrexone SRBupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
Sponsor:
Orexigen Therapeutics Inc
Organization:
Orexigen Therapeutics Inc
Organization Data
Organization:
Orexigen Therapeutics Inc
Class:
INDUSTRY
Study ID:
NB-304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Orexigen Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None